Trade Idea of the Day: Short Vertex

Vertex Pharmaceuticals (NASDAQ: VRTX ) has a technical set-up that had gone from bad to worse entering the second half of 2013. Now, it has become downright ugly. While recent weakness in Biotech (see: XBI) has put some pressure on Vertex, the company did itself no favors with an absolutely